TNF and rheumatoid arthritis: RA is an autoimmune disorder, and although several therapeutics are approved for the treatment of patients with an inadequate response to methotrexate (MTX) or tumor necrosis factor inhibitors (anti-TNF) (3–9), some patients become refractory to currently available therapeutics and may benefit from therapy utilizing a different mechanism of action (6,8–12).